These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12870014)

  • 21. [A comparative characteristic of antigenic properties of recombinant and native hbs-antigens with G145R mutation and evaluation of their immunogenicity].
    Konopleva MV; Borisova VN; Sokolova MV; Feldsherova AA; Krymskij MA; Semenenko TA; Suslov AP
    Vopr Virusol; 2017; 62(4):179-186. PubMed ID: 29733168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Yamaguchi K
    J Virol Methods; 2006 Sep; 136(1-2):254-6. PubMed ID: 16707169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccination.
    Davaalkham D; Ojima T; Uehara R; Watanabe M; Oki I; Endo K; Takahashi M; Okamoto H; Nakamura Y
    Arch Virol; 2007; 152(3):575-84. PubMed ID: 17115304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.
    Jeantet D; Chemin I; Mandrand B; Tran A; Zoulim F; Merle P; Trepo C; Kay A
    J Med Virol; 2004 Aug; 73(4):508-15. PubMed ID: 15221893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of eukaryotic expression vector expressing hepatitis B virus HBsAg and EGFP fusion protein and establishment of stable transfected Chang Liver cell line].
    Mu JS; Wang HF; Wang JH; Pan XB; Zhang L; Wei L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):228-30. PubMed ID: 19031712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
    Lei CL; Huang CH; Yang Z; Tang XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of amino acid sequence variation of a determinant(s) on the antigenic properties of hepatitis B virus HBsAg].
    Ulanova TI; Yokosawa J; Puzyrev VF; Obriadina AP; Burkov AN; Khudyakov Y; Fields H
    Vopr Virusol; 2007; 52(3):13-5. PubMed ID: 17601044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of HBsAg by using various eukaryotic expression vectors].
    Gu B; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):98-100. PubMed ID: 10488419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
    Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
    Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
    Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
    Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus genotypes and precore mutations in Scottish blood donors.
    Davidson F; Lycett C; Sablon E; Petrik J; Dow BC
    Vox Sang; 2005 Feb; 88(2):87-92. PubMed ID: 15720605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
    Tan GH; Yusoff K; Seow HF; Tan WS
    J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
    Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
    J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.